on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech publishes its 2025 Universal Registration Document
Sartorius Stedim Biotech SA has announced the availability of its 2025 Universal Registration Document. This document, essential for investors, is accessible online. It contains key information on the company's business performance during the 2025 financial year and details the objectives set for 2026.
In addition, the consolidated financial statements as of December 31, 2025, are included. This information provides crucial financial insights for understanding the economic health and outlook of Sartorius Stedim Biotech. The company, listed on Euronext Paris, generated revenues of approximately €3 billion in 2025.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news